PDA

View Full Version : Press Releases

  1. American Red Cross Expands Agreement for Strategic Blood Management Services
  2. FDA Approves Nplate™ For Long-Term Treatment Of Adult Chronic ITP
  3. New free-standing clinic in Arkansas
  4. Nano Tech Hemostat!
  5. Synthetic Blood Announces Department of Defense Grant for Traumatic Brain Injury Clin
  6. Blood clotting protein linked to rheumatoid arthritis
  7. Z-Medica now has retail products
  8. Hemo Concepts to Launch Integrated Blood Conservation Program At Texas Heart Institut
  9. Baxter Issues Urgent Nationwide Voluntary Recall of Heparin...
  10. FDA Approves Sealant to Control Bleeding During Surgery
  11. Blood Transfusions May Be Harmful To Some Patients
  12. FDA Approves Voluven to Treat Serious Blood Volume Loss following Surgery
  13. Creighton University Medical Center Accredited by ABC.
  14. BBC article
  15. Bayer Stops Worldwide Sales of Trasylol Pending Safety Data
  16. FDA Approves Mircera: First Renal Anemia Treatment in the US with Monthly Maint...
  17. Bayer Yanks Aprotinin off the Market Pending Analysis of BART
  18. Synthetic Blood International's Oxycyte Featured on PBS' WIRED Science
  19. FDA Sides With CMS in EPO Battle; Labeling Change Next
  20. Medical Study Proves Claims of Natural Extract to Increase Circulating Stem Cells
  21. Stored blood lacks nitric oxide-Yahoo news
  22. Bloodless Cardiac Surgery in Jehovah's Witnesses: Outcomes Compared
  23. Biochip that guarantees safety in blood transfusions
  24. Alliance Pharmaceutical Corp. Completes the Manufacture of Oxygent (TM) for Clinical
  25. Bayer Discontinues Trasylol(R) Clinical Trial Program in Non-CABG Indications
  26. A Recombinant EPO and Albumin Fusion
  27. Pre-operative Assessment - Jehovah’s Witnesses (UK Dept of Health)
  28. Anemic Children with Cancer Benefit from Erythropoietin
  29. Blood Avoidance Program Gives Families Options; DeVos Children's Hospital
  30. St. Vincent Healthcare Blood Conservation Program in the news!
  31. ALLIANCE PHARMA - April 20th/2006
  32. Akzo Nobel's Ferrazone iron compound receives FDA acceptance
  33. Alliance Pharmaceutical Corp. Reaches Agreement With Lender Committee.
  34. Hemo Concepts Contracts with Nebraska Methodist Hospital on Blood Conservation
  35. Hemosol has Filed a Notice of Intention to Make a Proposal to its Creditors
  36. Blood Conservation Strategies - Emory University Hospital Forum
  37. PolyHeme Trial to Begin Monday at Duke University Hospital
  38. Substituting blood transfusions
  39. Developing a 'Super'-EPO
  40. FDA Clears Novare's EndoLink(TM) Articulating Instruments for Marketing; Six Degrees
  41. Nuvelo Begins Phase 3 Trial of Alfimeprase for Acute Peripheral Arterial Occlusion, o
  42. MedicalCV Announces Completion of a Series of U.S. Clinical Cases Using the ATRILAZE(
  43. Bayer Initiates Phase III Clinical Study of Trasylol(R) Therapy During Primary Total
  44. Northfield Laboratories Inc. Announces Result of Third Interim Analysis of PolyHeme P
  45. REVLIMID(R) New Drug Application Submitted to FDA for Review
  46. ATS Medical to Participate in the American Association for Thoracic Surgery Meeting
  47. New Research Shows Three Innovative Nonsurgical Bone Tumor Treatments Provide Pain Re
  48. Nonsurgical Cryotherapy for Prostate Cancer, the 'Male Lumpectomy,' Preserves
  49. Biopure Completes Patient Enrollment in European Phase 2 Clinical Trial of Hemopure(R
  50. ThermoGenesis Corp. to Supply Autologous Thrombin Kits to Biomet, Inc.
  51. Alliance Pharmaceutical Corp. and Beijing Double-Crane Pharmaceutical Co., Ltd. Annou
  52. Gish Cardiopulmonary Bypass Equipment Used in Pioneering Transfusion-free Surgery
  53. Transfusion-Free Surgery
  54. Physician response to conflicts between faith and medicine
  55. Heart attack patients who receive blood transfusions have higher death rate
  56. Vitamin B12 Taken Nasally Can Help Patients Starve off Anemia After Gastric Bypass
  57. Blood alternative reduces risk of disease
  58. New Innovative Non-Surgical Cardiac Procedure Provided at Trinitas: Elizabeth, NJ
  59. Haemonetics to Market First Non-Invasive Test for Blood Hematocrit
  60. ProMetic Announces that PRDT's Ligand Technology Binds and Removes Viruses from Blood
  61. Alternative blood salvage device to cell savers
  62. Ready System® 200 as an Alternative to the Traditional Heart Lung Machine and CABG
  63. Aggrastat(R), Added to Heparin, Reduced Complications From Unstable Angina
  64. No Need For Transfusions With New Blood Washer
  65. Biopure Receives FDA Response to Hemopure(R) Marketing Application
  66. U.S. FDA Finalizes Response Date for Biopure's Marketing Application of Hemopure
  67. Sangart Initiates Phase Ib/ii Clinical Trial For Hemospan(tm)
  68. Tissuelink Medical
  69. Tissuelink Medical Receives Fda Clearance For The Hemostatic Sealing And ...